X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs UNICHEM LAB - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH UNICHEM LAB STERLING BIOTECH/
UNICHEM LAB
 
P/E (TTM) x -0.4 284.1 - View Chart
P/BV x 0.0 0.7 2.2% View Chart
Dividend Yield % 0.0 2.6 -  

Financials

 STERLING BIOTECH   UNICHEM LAB
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
UNICHEM LAB
Mar-18
STERLING BIOTECH/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs11382 2.7%   
Low Rs3234 1.5%   
Sales per share (Unadj.) Rs26.8116.3 23.1%  
Earnings per share (Unadj.) Rs-15.0-18.9 79.0%  
Cash flow per share (Unadj.) Rs-5.5-11.7 46.5%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %01.6 0.0%  
Book value per share (Unadj.) Rs54.9381.0 14.4%  
Shares outstanding (eoy) m267.8770.34 380.8%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.32.6 9.8%   
Avg P/E ratio x-0.5-16.3 2.9%  
P/CF ratio (eoy) x-1.3-26.2 4.8%  
Price / Book Value ratio x0.10.8 15.7%  
Dividend payout %0-26.4 0.0%   
Avg Mkt Cap Rs m1,86221,668 8.6%   
No. of employees `0001.42.3 59.4%   
Total wages/salary Rs m5472,006 27.3%   
Avg. sales/employee Rs Th5,303.33,587.8 147.8%   
Avg. wages/employee Rs Th403.8880.0 45.9%   
Avg. net profit/employee Rs Th-2,959.0-583.7 506.9%   
INCOME DATA
Net Sales Rs m7,1818,180 87.8%  
Other income Rs m43610 7.0%   
Total revenues Rs m7,2238,790 82.2%   
Gross profit Rs m947-1,320 -71.7%  
Depreciation Rs m2,543505 503.5%   
Interest Rs m4,37780 5,464.5%   
Profit before tax Rs m-5,931-1,295 457.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,92433 -5,757.9%   
Profit after tax Rs m-4,007-1,331 301.0%  
Gross profit margin %13.2-16.1 -81.7%  
Effective tax rate %32.4-2.6 -1,257.5%   
Net profit margin %-55.8-16.3 342.9%  
BALANCE SHEET DATA
Current assets Rs m14,33523,318 61.5%   
Current liabilities Rs m49,8094,635 1,074.6%   
Net working cap to sales %-494.0228.4 -216.3%  
Current ratio x0.35.0 5.7%  
Inventory Days Days403122 331.3%  
Debtors Days Days171121 140.5%  
Net fixed assets Rs m55,4328,163 679.0%   
Share capital Rs m268141 190.4%   
"Free" reserves Rs m13,93526,660 52.3%   
Net worth Rs m14,70126,801 54.9%   
Long term debt Rs m9,4783 287,207.6%   
Total assets Rs m73,98831,890 232.0%  
Interest coverage x-0.4-15.2 2.3%   
Debt to equity ratio x0.60 523,588.0%  
Sales to assets ratio x0.10.3 37.8%   
Return on assets %0.5-3.9 -12.8%  
Return on equity %-27.3-5.0 548.8%  
Return on capital %-6.4-4.5 141.5%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Exports (fob) Rs m1,860NA-   
Imports (cif) Rs m12NA-   
Fx inflow Rs m1,8604,356 42.7%   
Fx outflow Rs m250-   
Net fx Rs m1,8354,356 42.1%   
CASH FLOW
From Operations Rs m1,719-1,123 -153.0%  
From Investments Rs m-3,14816,487 -19.1%  
From Financial Activity Rs m1,426-8,811 -16.2%  
Net Cashflow Rs m-36,552 -0.1%  

Share Holding

Indian Promoters % 33.9 50.1 67.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 15.1 -  
FIIs % 9.9 3.0 330.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 31.7 124.0%  
Shareholders   21,482 20,176 106.5%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   BIOCON   CADILA HEALTHCARE  VENUS REMEDIES  PANACEA BIOTECH  WOCKHARDT  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Downtrend; Sensex Ends 495 Points Lower(Closing)

Indian share markets witnessed most of the selling pressure during closing hours and ended their trading session on a negative note.

Related Views on News

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS